CAR-T Meeting 2020 | CAR T-cell therapy access and reimbursement: the patient’s perspective

Name: CAR T-cell therapy access and reimbursement: the patient’s perspective
Uploaded: 2020-01-30T00:00:00.000Z
Duration: 2 min 20 s
Description: Bregje Verhoeven, European Society for Blood & Marrow Transplantation (EBMT), Leiden, The Netherlands, discusses the access and reimbursement of CAR T-cell therapy, it's importance and the patients’ perspective of CAR T-cell therapy regulation. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Bregje Verhoeven • 30 Jan 2020

CAR-T Meeting 2020

General CAR-T

Bregje Verhoeven, European Society for Blood & Marrow Transplantation (EBMT), Leiden, The Netherlands, discusses the access and reimbursement of CAR T-cell therapy, it’s importance and the patients’ perspective of CAR T-cell therapy regulation. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.